TPI [TIANYIN PHARMACEUTICAL] 10-Q/A: (Original Filing)

[FORM 10-Q/A (Amendment No. 1) (Mark One) For the quarterly period ended March 31, 2011 For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Guoqing Jiang Chief Executive Officer & Chairman] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong James Jiayuan Tong Chief Financial Officer, Chief Accounting Officer, Chief Business and Development Officer,]

By | 2016-03-27T20:27:37+00:00 August 22nd, 2011|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 10-Q/A: (Original Filing)

[FORM 10-Q/A (Amendment No. 1) (Mark One) For the quarterly period ended December 31, 2010 For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q/A of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2)T he information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer & Chairman] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Chief Accounting Officer, Chief Business and Development Officer, Director]

By | 2016-03-27T20:29:25+00:00 August 22nd, 2011|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

NTES [NetEase,] CORRESP: (Original Filing)

[[Letterhead of NetEase.com, Inc.] August 12 , 2011 Ms. Mara Ransom Ms. Angie Kim Mr. William Thompson Mr. James Allegretto Mr. Adam Phippen Division of Corporation Finance 100 F Street, N.E. Re: NetEase.com, Inc. (the “Company”) Form 20-F for the Fiscal Year Ended December 31, 2010 Filed June 22, 2011 File No. 0-30666 (the “2010 Form 20-F”) Dear Ms. Ransom,]

By | 2016-02-28T15:01:58+00:00 August 19th, 2011|Categories: Chinese Stocks, NTES, SEC Original|Tags: , , , , , |0 Comments

NTES [NetEase,] CORRESP: (Original Filing)

[[Letterhead of NetEase.com,Inc.] August12 , 2011 Ms.Mara Ransom Ms.Angie Kim Mr.William Thompson Mr.Jameslegretto Mr.Adam Phippen Division ofrporation Finance 100 F Street, N.E. Re: NetEase.com,Inc. (thempany) Form20-F for the Fiscal Year Ended December31, 2010 Filed June22, 2011 File No.0-30666 (the 2010 Form20-F) Dear Ms.Ransom, Ms.Kim, Mr.Thompson, Mr.Allegretto and Mr.Phippen:]

By | 2016-02-03T21:53:51+00:00 August 19th, 2011|Categories: Chinese Stocks, NTES, SEC Original|Tags: , , , , , |0 Comments

NTES [NetEase,] CORRESP: (Original Filing)

[[Letterhead of NetEase.com,Inc.] August12 , 2011 Ms.Mara Ransom Ms.Angie Kim Mr.William Thompson Mr.Jameslegretto Mr.Adam Phippen Division ofrporation Finance 100 F Street, N.E. Re: NetEase.com,Inc. (thempany) Form20-F for the Fiscal Year Ended December31, 2010 Filed June22, 2011 File No.0-30666 (the 2010 Form20-F) Dear Ms.Ransom, Ms.Kim, Mr.Thompson, Mr.Allegretto and Mr.Phippen:]

By | 2016-02-03T13:55:24+00:00 August 19th, 2011|Categories: Chinese Stocks, NTES, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] CORRESP: (Original Filing)

[China Pharma Holdings, Inc. Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 August 19, 2011 Division of Corporation Finance 100 F Street, NE Mail Stop: 3561 Attention: Jim B. Rosenberg, Senior Assistant Chief Accountant Re: China Pharma Holdings, Inc. Form 10-K for the Fiscal Year Ended December 31, 2010 Filed March 3, 2011 and Amended March 17,]

By | 2016-03-03T19:12:17+00:00 August 19th, 2011|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

NTES [NetEase,] CORRESP: (Original Filing)

[[Letterhead of NetEase.com,Inc.] August12 , 2011 Ms.Mara Ransom Ms.Angie Kim Mr.William Thompson Mr.Jameslegretto Mr.Adam Phippen Division ofrporation Finance 100 F Street, N.E. Re: NetEase.com,Inc. (thempany) Form20-F for the Fiscal Year Ended December31, 2010 Filed June22, 2011 File No.0-30666 (the 2010 Form20-F) Dear Ms.Ransom, Ms.Kim, Mr.Thompson, Mr.Allegretto and Mr.Phippen:]

By | 2016-02-03T08:07:51+00:00 August 19th, 2011|Categories: Chinese Stocks, NTES, SEC Original|Tags: , , , , , |0 Comments

GSOL [GLOBAL SOURCES] 6-K: (Original Filing)

[nd YEAR 2011 / 2 RESULTS OF OPERATIONS OF GLOBAL SOURCES LTD. The following discussion of our financial condition and results of operations should be read in conjunction with the accompanying financial statements. Overview We are a leading business-to-business (B2B) media company and a primary facilitator of two-way trade with Greater China. The core business is facilitating trade from Greater] [GLOBAL SOURCES LTD. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (In U.S. Dollars Thousands, Except Number of Shares and Per Share Data) As at June 30, As at December 31, 2011 2010 (Unaudited) ASSETS Current assets Cash and cash equivalents $ 132,911 $ 101,298 Term deposits with banks 1,032 1,411 Accounts receivables] [GLOBAL SOURCES LTD. AND SUBSIDIARIES ACTUAL GAAP TO IFRS RECONCILIATION (In U.S. Dollars Thousands) Three months Six months ended June 30, ended June 30, 2010 2010 U.S. GAAP Net Income Attributable to the Company $ 7,250 $ 9,839 IFRS conversion adjustments:]

By | 2016-03-07T18:31:40+00:00 August 19th, 2011|Categories: Chinese Stocks, GSOL, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar